Patent Assignment
Reel/Frame 039894/0473
Release of Security Interest
Recorded: 2016-09-29
Pages: 7
Assignor
KREOS CAPITAL IV (UK) LIMITED
Executed: 2015-10-09
Assignee
NABRIVA THERAPEUTICS AG
LABERSTRASSE 20, WIEN, 1110, AUSTRIA
Covered Properties
(3)
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
14/283,734 →
Publication:
US 2014/0256731
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest
Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Assignment of Assignor's Interest
Oct 13, 2014
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033934/0969 →
Assignment of Assignor's Interest
Oct 13, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033935/0048 →
Change of Name
Jul 18, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047958/0106 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →